---

Overview

Cephalexin is a cephalosporin antibiotic used to treat certain infections caused by susceptible bacteria. Keflex is a commonly recognized brand name associated with Cephalexin.

Current DailyMed prescribing information lists Cephalexin for certain respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections caused by susceptible bacteria. Antibiotics such as Cephalexin should be used for infections proven or strongly suspected to be bacterial, not viral illnesses such as cold or flu.

For home health nurses, Cephalexin indication and home health teaching often focuses on identifying why antibiotic was ordered, following prescribed therapy, monitoring whether infection symptoms are improving or worsening, recognizing medication-related concerns, reviewing allergy history, reporting significant diarrhea, and knowing when to notify PCP/provider or call 911.

SN should not assume Cephalexin was prescribed for a wound infection, UTI, respiratory infection, or any other diagnosis simply because medication appears on medication list.

Patient-specific indication should be verified from current provider order, medication profile, Hospital discharge instructions, pharmacy label, or clarified PCP/provider instructions.

Cephalexin helps treat susceptible bacterial infection as prescribed, but antibiotic therapy does not guarantee infection resolution.

---

Medication Quick Information

Item	Information
Generic name	Cephalexin
Common brand name(s)	Keflex is a commonly recognized brand name; generic Cephalexin products are commonly used
Drug classification	Cephalosporin antibacterial / antibiotic
Common home health teaching focus	Patient-specific indication, prescribed antibiotic completion, medication adherence, infection symptom monitoring, allergy review, GI side effect reporting, severe diarrhea awareness, medication-list review, PCG support when needed, and when to notify PCP/provider or call 911

---

Common Indications for Cephalexin

Common provider-ordered indications may include:

• Certain bacterial respiratory tract infections.
• Otitis media caused by susceptible bacteria.
• Skin and skin structure infections caused by susceptible bacteria.
• Certain bacterial bone infections.
• Genitourinary tract infections caused by susceptible bacteria, including acute prostatitis in appropriate patients.

DailyMed specifically identifies these infection categories as approved indications for Cephalexin when caused by susceptible organisms.

In home health, Cephalexin may therefore be seen in patients receiving treatment for an applicable skin or soft-tissue infection, bacterial urinary infection, or another provider-diagnosed bacterial infection.

Do not assume every wound, urinary symptom, cough, or respiratory complaint requires Cephalexin.

Medication selection depends on patient diagnosis, suspected or identified bacteria, clinical findings, allergy history, culture information when available, provider judgment, and other patient-specific considerations.

Verify patient-specific reason before teaching or documenting indication.

---

Short EMR Indication Options

Verify patient-specific reason before use. The examples below are possible Short EMR Indication Options. Select only the indication that matches patient diagnosis, provider order, medication profile, discharge instructions, pharmacy label, or clarified PCP/provider instruction.

Patient diagnosis / reason	Short EMR indication option
Bacterial respiratory tract infection	Bacterial respiratory infection
Otitis media	Bacterial otitis media
Skin and skin structure infection	Skin / skin structure infection
Provider-diagnosed cellulitis	Cellulitis treatment
Bacterial genitourinary infection	Bacterial GU infection
Provider-diagnosed urinary tract infection	Bacterial UTI treatment
Acute prostatitis, when specifically documented	Acute prostatitis treatment
Bacterial bone infection	Bacterial bone infection

Do not use “cephalosporin therapy,” “antibiotic therapy,” or “medication compliance support” as patient-specific indication unless provider documentation clearly identifies that wording as clinical reason.

---

What SN Should Verify Before Teaching

Before providing Cephalexin teaching, SN should review current order and patient-specific infection information.

Important items to verify include:

• Medication name: Confirm Cephalexin is correctly listed on current medication profile.
• Patient-specific indication: Identify infection being treated.
• Provider instructions: Verify ordered dose, frequency, duration, and formulation without independently changing instructions.
• Pharmacy label: Confirm instructions match current provider order and medication profile.
• Allergy history: Review known Cephalexin, cephalosporin, penicillin, beta-lactam, or other medication reactions.
• Current medication list: Review prescription medications, OTC products, supplements, and recent medication changes.
• Relevant medical history: Identify kidney disease, previous significant antibiotic-associated diarrhea or colitis, or other concerns requiring provider/pharmacist review.
• Current infection symptoms: Assess findings relevant to actual diagnosis and plan of care.
• Medication tolerance: Assess nausea, vomiting, diarrhea, poor intake, rash, itching, or other reported concerns.
• Follow-up plan: Verify ordered reassessment, testing, culture follow-up, or PCP/provider appointment when applicable.
• PCG support: Determine whether patient needs assistance with medication organization, symptom monitoring, or reporting.

Cephalexin is contraindicated in patients with known hypersensitivity to Cephalexin or other cephalosporins. Current prescribing information also instructs clinicians to ask about previous reactions to cephalosporins, penicillins, and other drugs because cross-hypersensitivity among beta-lactam antibiotics may occur. A history of penicillin allergy does not mean SN should independently decide whether Cephalexin is appropriate. Exact reaction history should be communicated and clarified with PCP/provider or pharmacist.

---

Home Health Teaching Focus

Home health Cephalexin teaching should connect medication to actual infection being treated.

Teaching should help patient or PCG understand:

• why Cephalexin was prescribed
• how to follow current provider and pharmacy instructions
• importance of following prescribed antibiotic treatment while recognizing suspected serious medication reactions that require prompt or urgent clinical evaluation
• what infection symptoms should be monitored
• how to recognize medication-related concerns
• when diarrhea requires prompt reporting
• why allergy symptoms matter
• when PCP/provider should be contacted
• when symptoms require 911

Teaching should be individualized rather than giving same general antibiotic education at every visit.

Basic Patient / PCG Teaching

Basic teaching may include:

• Take Cephalexin exactly as prescribed and follow current pharmacy label and provider instructions.
• Complete prescribed antibiotic therapy unless treating provider changes instructions or a suspected serious medication reaction requires urgent evaluation.
• Do not independently extend therapy, take extra medication, or use leftover antibiotics for a future illness.
• Do not share Cephalexin with another person.
• Contact PCP/provider or pharmacist for missed-dose instructions rather than independently changing schedule.
• Monitor whether infection symptoms are improving, unchanged, or worsening.
• Report persistent nausea, vomiting, or poor intake to PCP/provider. New rash, itching, hives, or other suspected allergic symptoms require prompt medical assessment before another Cephalexin dose.
• Severe, persistent watery or bloody diarrhea, especially with significant cramping, fever, weakness, or poor intake, requires urgent medical evaluation, including when symptoms develop after antibiotic therapy ends.
• Keep updated medication and allergy list.
• Follow ordered PCP/provider reassessment, laboratory testing, culture follow-up, or other infection-related follow-up when applicable.

---

Medication Safety and Follow-Through

Medication Adherence and Prescribed Completion

MedlinePlus advises patients to take Cephalexin exactly as directed and complete prescribed treatment even if they begin feeling better. Stopping too early or skipping treatment may leave infection incompletely treated and contribute to antibiotic resistance.

For home health teaching:

• Reinforce current provider and pharmacy instructions.
• Reinforce completing prescribed treatment unless authorized provider changes instructions or a suspected serious medication reaction requires urgent evaluation.
• Do not independently recommend extending antibiotic therapy because symptoms remain.
• Do not recommend saving leftover medication for future illness.
• Do not recommend sharing medication.
• Do not provide independent missed-dose instructions.
• Report adherence problems, medication confusion, vomiting, poor intake, or difficulty completing therapy to PCP/provider or pharmacist.

Routine antibiotic-completion teaching does not override serious medication-reaction precautions. If an allergic reaction is suspected, obtain prompt clinical assessment before further Cephalexin use. Current prescribing information directs discontinuation and appropriate treatment when an allergic reaction occurs. Severe breathing difficulty, significant facial or throat swelling, collapse, or other life-threatening symptoms require 911.

Infection Symptom Monitoring

Patient and PCG should know what infection-specific findings to monitor based on actual diagnosis.

If Cephalexin was ordered for a skin or wound-related infection, monitoring may include:

• redness
• warmth
• swelling
• drainage
• increased pain
• surrounding skin changes
• worsening wound appearance
• systemic symptoms when present

If Cephalexin was ordered for a urinary or genitourinary infection, monitoring may include:

• burning
• urgency
• frequency
• pelvic or lower abdominal discomfort
• urine changes when relevant
• fever or chills
• worsening weakness or confusion

If Cephalexin was ordered for a respiratory infection, monitoring may include:

• cough changes
• sputum changes when applicable
• worsening shortness of breath
• chest symptoms
• fatigue
• fever or chills
• decline from baseline

Only document and teach findings relevant to patient-specific diagnosis and plan of care.

If infection symptoms fail to improve or worsen, patient should contact PCP/provider according to ordered follow-up plan.

Allergy Awareness

Cephalexin can cause hypersensitivity reactions, including serious reactions such as anaphylaxis, angioedema, urticaria, and severe skin reactions.

Before and during therapy:

• Review known medication allergies.
• Ask patient or PCG what previous antibiotic reaction involved rather than documenting only “penicillin allergy” without details when information is available.
• Report new rash, itching, hives, swelling, or other suspected allergic symptoms promptly. Obtain medical guidance before further Cephalexin use. Call 911 for severe or life-threatening allergic symptoms.
• Follow PCP/provider or pharmacist instructions regarding non-emergency suspected reactions.
• Do not independently substitute another antibiotic.
• Call 911 for severe breathing difficulty, significant facial/lip/tongue/throat swelling, collapse, unresponsiveness, or other life-threatening allergic symptoms.

A history of penicillin allergy requires clinical review but should not automatically be interpreted by SN as meaning Cephalexin can never be used. Provider/pharmacy guidance and patient-specific reaction history should guide care.

Severe skin reactions have also been reported with Cephalexin. New blistering or peeling skin, or painful sores involving mouth or other mucous membranes, require urgent medical evaluation. Do not wait for routine PCP follow-up.

Severe Diarrhea and Antibiotic-Associated Complications

Diarrhea is one of most frequently reported adverse reactions with Cephalexin. Cephalexin and other antibiotics may also be associated with Clostridioides difficile-associated diarrhea, which can range from mild diarrhea to severe colitis. This complication may occur during treatment or more than two months after antibiotic exposure.

Patient and PCG should report:

• severe diarrhea
• persistent watery diarrhea
• bloody stool
• significant abdominal cramping
• fever associated with diarrhea
• worsening weakness or poor intake associated with diarrhea
• diarrhea that begins after antibiotic therapy has ended

Severe, persistent watery or bloody diarrhea, especially with significant abdominal cramping, fever, weakness, or poor intake, requires urgent medical evaluation rather than routine PCP follow-up. This concern also applies when diarrhea begins after antibiotic treatment has ended.

SN should not independently diagnose C. difficile, recommend OTC diarrhea treatment, or change antibiotic therapy without appropriate provider instructions. Call 911 if patient develops collapse, unresponsiveness, or other severe or life-threatening symptoms.

Hydration and Intake

Nausea, vomiting, diarrhea, poor appetite, or infection itself may affect oral intake.

Reinforce hydration and nutrition only according to patient condition, provider instructions, diet or fluid orders, and plan of care.

Do not provide universal fluid recommendations, particularly when patient has CHF, kidney disease, fluid restrictions, or other conditions requiring individualized management.

Medication List Review

Medication reconciliation remains important during antibiotic therapy.

Current Cephalexin labeling identifies several medication-specific precautions.

Cephalexin can increase metformin exposure. For patients also taking metformin, review current medication list and provider-directed Blood Sugar monitoring, and report relevant low Blood Sugar symptoms or other concerns to PCP/provider or pharmacist.

Probenecid can reduce Cephalexin elimination through kidneys. Concurrent use is not recommended in reviewed prescribing information and requires prescriber/pharmacist review.

Kidney impairment can increase Cephalexin exposure and certain adverse-effect risks, including seizures. Cephalosporins may also be associated with prolonged prothrombin time, particularly in patients with renal or hepatic impairment, poor nutritional status, prolonged antibiotic treatment, or anticoagulant therapy.

Review relevant history, medication interactions, and ordered monitoring. Do not independently adjust medications or prescribe laboratory testing.

SN should:

• Maintain current medication list.
• Identify medication changes or discrepancies.
• Refer potential interaction concerns to PCP/provider or pharmacist.
• Avoid independently stopping, changing, or adjusting another medication.

---

Common Side Effects

Possible Cephalexin side effects may include:

• diarrhea
• nausea
• vomiting
• stomach pain or abdominal discomfort
• indigestion
• heartburn
• headache
• dizziness
• fatigue
• genital or anal itching
• symptoms of yeast overgrowth in some patients

DailyMed identifies diarrhea as most frequent adverse reaction in clinical trials, with nausea, vomiting, dyspepsia, gastritis, and abdominal pain also reported.

Not every patient will experience these symptoms.

---

Reportable Medication Concerns

Contact PCP/provider or pharmacist for non-emergency medication concerns according to severity and agency policy. Suspected serious medication reactions may require prompt or urgent medical evaluation rather than routine notification. Call 911 for severe or life-threatening symptoms.

• persistent nausea or vomiting
• poor intake affecting ability to follow treatment
• worsening diarrhea
• severe or persistent watery diarrhea
• bloody stool
• significant abdominal pain or cramping
• rash, itching, or hives
• new swelling
• medication intolerance
• new confusion or unusual change from baseline
• infection symptoms getting worse
• infection symptoms not improving as expected
• medication error or possible duplicate antibiotic
• missed-dose concerns
• allergy-history concern
• difficulty completing prescribed therapy
• refill or supply problem
• patient or PCG uncertainty about medication instructions
• New blistering or peeling skin, or painful sores involving mouth or other mucous membranes, requiring urgent evaluation.
• Unusual bleeding or bruising, particularly when patient has relevant bleeding risk or anticoagulant therapy, requiring prompt clinical assessment.

Emergency symptoms should not wait for routine PCP/provider communication.

---

When to Notify PCP / Provider

Notify PCP/provider or follow agency reporting procedures for:

• Infection symptoms that are not improving or are becoming worse.
• New or increasing redness, warmth, swelling, drainage, or pain when treating applicable skin or wound-related infection.
• Persistent or worsening urinary symptoms when Cephalexin is being used for applicable genitourinary infection.
• Persistent or worsening respiratory symptoms when applicable.
• Fever, chills, worsening weakness, or other infection-related changes requiring clinical review.
• Significant nausea, vomiting, poor intake, or difficulty completing prescribed therapy.
• Severe, persistent watery or bloody diarrhea, especially with significant abdominal cramping, fever, weakness, or poor intake. Arrange urgent medical evaluation rather than waiting for routine PCP follow-up.
• New rash, itching, hives, or other suspected allergic symptoms. Obtain prompt medical assessment before further Cephalexin use. Severe allergic symptoms require 911.
• Medication confusion, missed-dose concern, possible medication error, or duplicate therapy concern.
• Known antibiotic allergy that has not been clarified.
• Medication interaction concern.
• Refill or medication supply problem.
• Patient or PCG unsure how to follow prescribed antibiotic instructions.
• New or worsening symptoms after antibiotic therapy is completed.
• New blistering or peeling skin, painful mucosal sores, unusual bleeding or bruising, or concerning neurological changes. Arrange prompt or urgent clinical evaluation according to severity. Seizure or other life-threatening symptoms require 911.

Follow agency policy for urgency of provider notification and documentation of communication.

---

When to Call 911

Call 911 for severe or life-threatening symptoms. Follow agency emergency protocol as applicable without delaying emergency response.

Emergency symptoms may include:

• Severe trouble breathing.
• Significant swelling of face, lips, tongue, or throat.
• Severe allergic reaction with respiratory distress.
• Collapse.
• Unresponsiveness or inability to wake normally.
• Seizure.
• Severe confusion with inability to respond normally.
• Severe chest pain or severe shortness of breath.
• Rapid clinical deterioration with severe weakness or inability to respond.
• Any other severe or life-threatening symptoms.

Serious allergic reactions require immediate emergency response. Do not delay 911 to obtain routine PCP/provider notification.

---

Home Health Documentation Considerations

Public Cephalexin documentation support should remain concise.

A useful SN note should reflect:

Patient-specific reason
Why Cephalexin is ordered based on current provider documentation.

Relevant assessment
Infection symptoms or medication concerns actually assessed during visit.

Teaching provided
Medication purpose, prescribed completion, infection monitoring, allergy awareness, GI concerns, diarrhea reporting, or other patient-specific teaching.

Patient / PCG response
Actual understanding, teach-back, barriers, participation, or need for reinforcement.

Provider communication
Abnormal findings or medication concerns reported to PCP/provider, only when communication actually occurred.

Follow-up
Plan for reassessment based on patient condition, provider instructions, and plan of care.

Avoid generic documentation such as:

“SN taught antibiotic. Patient verbalized understanding.”

Full teaching scripts, copy-ready charting phrases, patient/PCG response wording, ongoing skilled need phrases, weak vs stronger documentation examples, and quick charting support are included in restricted Premium Library section below.

---

---

Important Use Note

This post is for educational and home health teaching support only.

Cephalexin use, indication, prescribed instructions, duration of therapy, medication monitoring, infection reassessment, and reporting requirements should be individualized to patient condition, provider order, medication profile, Hospital discharge instructions, pharmacy label, plan of care, agency policy, payer requirements, and skilled nursing judgment.

This post does not provide:

• dosing recommendations
• renal-dose adjustments
• independent missed-dose instructions
• medication adjustment instructions
• instructions to independently extend antibiotic therapy
• antibiotic selection
• allergy diagnosis
• laboratory interpretation
• universal Vital Sign or temperature thresholds
• treatment instructions for C. difficile or other antibiotic-associated complications

Patients should follow current prescribed therapy and should not independently alter Cephalexin instructions.

Routine instructions to complete prescribed Cephalexin therapy do not override serious medication-reaction precautions. Suspected allergic symptoms require prompt medical assessment, and prescribing information directs discontinuation and appropriate treatment when an allergic reaction occurs.

Severe, persistent watery or bloody diarrhea requires urgent medical evaluation. Severe trouble breathing, significant facial/lip/tongue/throat swelling, seizure, collapse, unresponsiveness, or other life-threatening symptoms require 911.

This content does not replace provider orders, pharmacy guidance, discharge instructions, medication profile, agency policy, payer requirements, state regulations, emergency protocols, or skilled nursing judgment.

This content does not guarantee infection resolution, payment, claim approval, survey compliance, or regulatory compliance.

---

Sources Used for Medication Information

DailyMed: Cephalexin Capsules USP, current prescribing information
Current October 2026 labeling was used to verify bacterial infection indications, cephalosporin classification, hypersensitivity precautions, C. difficile-associated diarrhea, adverse reactions, medication interactions, and antimicrobial stewardship information.

View current Cephalexin prescribing information on DailyMed

MedlinePlus: Cephalexin Drug Information
Used to verify patient-facing information about bacterial infection treatment, prescribed therapy completion, common side effects, serious diarrhea and allergy symptoms, medication-list review, and follow-up when infection symptoms do not improve.

View Cephalexin information on MedlinePlus

Patient-specific medication use should always be verified with provider order, medication profile, Hospital discharge instructions, pharmacy label, plan of care, agency policy, and skilled nursing judgment.

---

---